Subscribe to Blog via Email
You’ve reached the website and blog of Ronny Allan. Glad you found this page, as there is a mountain of information, all carefully researched where applicable. This post is a list of your favourite posts as voted by you, the reader. How do you vote? Simple, you read posts that interest you, that pushes them up the league table over time. If you really like a particular post, you can easily share it too.
If your favourite post is not listed, just let me know, I’ll market it on your behalf.
As of November 14th, 2023. Shortcuts to my most read articles (over 5,000 views). Those listed individually have viewing counts over 20,000, the remainder is in a table (just keep scrolling) – click on the article title links on the left column to read, and please feel free to share. Does not include the home page which is currently running at over 83,000 views.
Today – the following figure is the total number of views of my blog! Can you help me get to 3 million?
- 2,311,109 views
What are the most-read blog posts in the last 48 hours?
Most read posts
Posts listed individually below have viewing counts over 20,000, just click the picture to read. The remainder (5,000-19,999) are in a table where you need to click on the article title links on the left column to read. Please feel free to share anything you want.
Posts with 5000 to 20,000 views
Click on the title to read the remaining popular articles. You can also just Google e.g. “Ronny Allan surgery”, “Ronny Allan chemotherapy” or “Ronny Allan Lanreotide”, etc etc etc, to find your subject of interest.
Didn’t find what you’re looking for? Google “Ronny Allan – insert your own term (e.g. surgery, chemotherapy, etc etc etc). i.e. “Ronny Allan Surgery” and you will get any post tagged with the term “Surgery”
I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or advised by me.
Neither should any post or comment made by a follower or member of my private group be assumed to be medical advice, even if that person is a healthcare professional.
Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the counter drugs and supplements such as vitamins and minerals.
General Clinical Trials Disclaimer
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided in the clinical trials document. It’s very important to check the trial inclusion and exclusion criteria before making any contact. If you need questions, the articles here is very useful Questions to Ask About Clinical Trials | Cancer.Net
The inclusion of any trial within this blog should not be taken as a recommendation by Ronny Allan.
Top 10 Posts & Pages in the last 48 hours (auto updates) (Click the titles to read them)
Thanks for reading.
Sign up for my newsletters – Click Here
Check out my Glossary of Terms – click here
Please Share this post for Neuroendocrine Cancer awareness and to help another patient
What is Carcinoid Syndrome? Carcinoid syndrome (CS) is the most frequent hormonal complication accompanying neuroendocrine neoplasms (NENs) and is defined by chronic diarrhoea and/or flushing in the
I was delighted to see this clinical trial which looks at the efficacy of PRRT (Lu177) vs the efficacy of Everolimus (Afinitor). The latter is
November is always busier as I help spread awareness for 10th Nov (remembering that every day is 10th Nov on my site!). I also managed
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for Digestive Neuroendocrine Carcinoma
This ENETS guidance paper, developed by a multidisciplinary working group, provides up-to-date and practical advice on the diagnosis and management of digestive neuroendocrine carcinoma, based
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastric neuroendocrine tumours (NETs) G1–G3
The ENETS 2023 guideline for gNETs are combined with the guidelines for Duodenal NET (dNET) due to their close relationship in anatomical terms. Gastric neuroendocrine
A cup of tea
I would also mention those who contributed to my “Tea Fund” which resides on PayPal. You don’t need a PayPal account as you can select a card but don’t forget to select the number of units first (i.e. 1 = £4, 2 = £8, 3 = £12, and so on), plus further on, tick a button to NOT create a PayPal account if you don’t need one. Clearly, if you have a PayPal account, the process is much simpler
Through your generosity, I am able to keep my sites running and provide various services for you. I have some ideas for 2023 but they are not detailed enough to make announcements yet.
This screenshot is from every single post on my website and depending on which machine you are using, it will either be top right of the post or at the bottom (my posts are often long, so scroll down!)